skip to main content
By Gareth Jennings |

Airbus Helicopters notes Covid-19 resilience for 2021 but expects impact in 2022

News
Share:
A downturn in Super Puma sales in particular could have ramifications for Airbus Helicopters' Marignane plant in southern France, according to the company's CEO.

Airbus Helicopters has said it is well placed to ride out the effects of the Covid-19 global pandemic, but expects the impact to be felt in 2022 as the order backlog is reduced.

A downturn in Super Puma sales in particular could have ramifications for Airbus Helicopters’ Marignane plant in southern France, according to the company’s CEO. (Airbus Helicopters)

A downturn in Super Puma sales in particular could have ramifications for Airbus Helicopters’ Marignane plant in southern France, according to the company’s CEO. (Airbus Helicopters)

Speaking to Janes and other media on 26 January, Airbus Helicopters CEO Bruno Even said that as current production is supported by orders placed in previous years and ongoing French government support, there should be no immediate effect on output. However, as these orders reach completion through 2021, he anticipates a relative shortfall in 2022.

“All orders confirmed before the crisis are being followed through, and this shows trust in Airbus Helicopters,” Even said. “2022 will be a challenge, where the impact will begin.” He noted that the company’s Marignane plant in southern France is especially vulnerable due to its reliance on the Super Puma range of helicopters, for which 2020 sales were down compared with previous years.

Go beyond the headlines - with direct links to interconnected entities

Get full access to validated equipment, military capabilities, and market insights.

Never miss updated intel from Janes.

Move faster with human-validated intelligence.

Get equipment and weapon intelligence that’s human-validated, connected, and ready for your mission workflow.

Message Received!

Message received. Thank you for getting in touch, our team will reach out to you soon.


In the meantime... check out our OSINT insights